URGN INVESTOR ALERT: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Provided By PR Newswire
Last update: May 29, 2025
SAN DIEGO, May 29, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the "Class Period"), have until July 28, 2025 to seek appointment as lead plaintiff of the UroGen class action lawsuit. Captioned Cockrell v. UroGen Pharma Ltd., 25-cv-06088 (D.N.J.), the UroGen class action lawsuit charges UroGen and certain of UroGen's top current and former executives with violations of the Securities Exchange Act of 1934.
Read more at prnewswire.com4.24
+0.27 (+6.8%)
Find more stocks in the Stock Screener
URGN Latest News and Analysis
17 days ago - ChartmillLet's have a look at the top gainers and losers one hour before the close of the markets of today's session.Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
17 days ago - ChartmillTop stock movements in today's session.Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
17 days ago - ChartmillThe market is filled with gapping stocks in Friday's session.The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
